2 terminated, 1 completed. 1 Early Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow C1-inhibitor: new trials by email Literature Review of C1-inhibitor trials Research Report on C1-inhibitor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C1-inhibitor in Allergic ASThma Patients C1-inhibitor, Saline, Antibiotics - Asthma | Phase 4 | Terminated | T. van der Poll | 37 | 2016-11-16 | 2020-06-24 |
| Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL) Antithrombin-III, Infliximab, Apotransferrin - Reperfusion Injury | Phase 2 | Completed | Universitaire Ziekenhuizen KU Leuven | 143 | 2014-09-01 | 2024-08-23 |
| Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor M5, C1-inhibitor - Acute Ischemic Stroke | Early Phase 1 | Terminated | TSI, LLC | 8 | 2012-09-01 | 2021-01-19 |
Angioedemas, Hereditary (2) · Asthma (1) · Brain Infarction (1) · Brain Ischemia (1) · Cardiovascular Diseases (1) · Cerebral Infarction (1) · Cerebrovascular Disorders (1) · Ischemia (1) · Ischemic Stroke (1) · Reperfusion Injury (1) · Stroke (1) · Vascular Diseases (1)
T. van der Poll (1) · TSI, LLC (1) · Universitaire Ziekenhuizen KU Leuven (1)
Netherlands (2) · Belgium (1)
Diethard Monbaliu, MD, PhD (1) · Koos Burggraaf, MD, PhD (1)